Enfermagem
Desempenho de crianças com fenilcetonúria no Teste de Screening de Desenvolvimento Denver - II*** Performance of children with phenylketonuria in the Developmental Screening Test - Denver II
Greyce Kelly da Silva* Dionísia Aparecida Cusin Lamônica*
*Fonoaudióloga. Mestre em Fonoaudiologia pela Faculdade de Odontologia da Universidade de São Paulo de Bauru (FOB/USP). Mestre no Teste de Screening de Desenvolvimento Denver II pela University of Colorado Health Sciences Center School of Medicine. Fonoaudióloga da Prefeitura Municipal de URU - SP. Endereço para correspondência: R. Alto Acre, 14-33 Bauru - SP - CEP 17063-080 (greycefono@uol.com.br). **Fonoaudióloga. Livre-Docente. Professora Associada do Departamento de Fonoaudiologia da FOB/USP. ***Trabalho Realizado no Departamento de Fonoaudiologia da FOB/USP, em Parceria com o Programa de Triagem Neonatal do Laboratório e Ambulatório de Screening Neonatal "Teste do Pezinho" da Associação de Pais e Amigos dos Excepcionais de Bauru.
Abstract Background: phenylketonuria is an autosomal recessive disorder resulting from the mutation of a gene located in chromosome 12q22-24.1. Aim: to describe the performance of children with classic phenylketonuria, who were diagnosed and treated early, in the Development Screening Test Denver - II. Method: participants were 20 children with phenylketonuria, ranging in age from 3 and 6 years, and 10 children with typical language development, paired by gender, age and socioeconomic level to the research group. The plasmatic phenylalanine measure and the neurological, psychological and social information were gathered in the data base of the Neonatal Screening Programs for Metabolic disorder. Assessment consisted on the application of the Development Screening Test Denver II. A descriptive statistical analysis and the Mann Whitney test were used in order to characterize the tested skills. For the measurements of the